Oxidative damage in the progression of chronic liver disease to hepatocellular carcinoma: An intricate pathway

World Journal of Gastroenterology

Volumn 20, Issue 12, 2014, Pages 3078-3086

  Cardin, Romilda ^a   Piciocchi, Marika ^a   Bortolami, Marina ^a   Kotsafti, Andromachi ^a   Barzon, Luisa ^a   Lavezzo, Enrico ^a   Sinigaglia, Alessandro ^a   Rodriguez Castro, Kryssia Isabel ^a   Rugge, Massimo ^a   Farinati, Fabio ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Antioxidant mechanisms; Cyto kines; Hepatocellular carcinoma; MicroR NA and circulating free DNA; Mitochondria; Reactive oxygen species; Telomere dysfunction; Viral hepatitis

Indexed keywords

ALPHA TOCOPHEROL; GLUTATHIONE TRANSFERASE P1; HYDROGEN PEROXIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; INTERLEUKIN 6; MENADIOL; MICRORNA; NITRIC OXIDE; POLYDEOXYRIBONUCLEOTIDE SYNTHASE; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A; REACTIVE OXYGEN METABOLITE; SUPEROXIDE; TELOMERASE; TRANSFORMING GROWTH FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA; ANTIOXIDANT; CYTOKINE;

3' UNTRANSLATED REGION; ALCOHOL CONSUMPTION; ANTIOXIDANT RESPONSIVE ELEMENT; APOPTOSIS; ARTICLE; CANCER INCIDENCE; CHRONIC INFLAMMATION; CHRONIC LIVER DISEASE; DEFENSE MECHANISM; DISEASE COURSE; DNA DAMAGE; DNA REPAIR; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER INJURY; MALIGNANT TRANSFORMATION; NONALCOHOLIC FATTY LIVER; OXIDATIVE STRESS; PROTEIN EXPRESSION; RISK FACTOR; TRANSLATION REGULATION; VIRUS HEPATITIS; ANIMAL; CARCINOMA, HEPATOCELLULAR; CELL PROLIFERATION; END STAGE LIVER DISEASE; FEMALE; GENETIC EPIGENESIS; INFLAMMATION; LIVER NEOPLASMS; MALE; METABOLISM; MITOCHONDRION; PATHOLOGY; SEX DIFFERENCE; TELOMERE; ULTRASTRUCTURE;

ANIMALS; ANTIOXIDANTS; APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CELL PROLIFERATION; CYTOKINES; DISEASE PROGRESSION; DNA REPAIR; END STAGE LIVER DISEASE; EPIGENESIS, GENETIC; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; HUMANS; INFLAMMATION; LIVER NEOPLASMS; MALE; MICRORNAS; MITOCHONDRIA; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; SEX FACTORS; TELOMERE;

EID: 84896990184     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i12.3078     Document Type: Article

References (74)

1. Mittal S, El-Serag HB. Epidemiology of hepatocellular carcinoma: consider the population. J Clin Gastroenterol 2013; 47 Suppl: S2-S6 [PMID: 23632345 DOI: 10.1097/ MCG.0b013e3182872f29]
2. Aravalli RN, Steer CJ, Cressman EN. Molecular mechanisms of hepatocellular carcinoma. Hepatology 2008; 48: 2047-2063 [PMID: 19003900 DOI: 10.1002/hep.22580]
3. Marrero JA, Kudo M, Bronowicki JP. The challenge of prognosis and staging for hepatocellular carcinoma. Oncologist 2010; 15 Suppl 4: 23-33 [PMID: 21115578 DOI: 10.1634/theon cologist.2010-S4-23]
4. Bertuccio P, Bosetti C, Levi F, Decarli A, Negri E, La Vecchia C. A comparison of trends in mortality from primary liver cancer and intrahepatic cholangiocarcinoma in Europe. Ann Oncol 2013; 24: 1667-1674 [PMID: 23378539 DOI: 10.1093/an-nonc/mds652]
5. El-Serag HB. Surveillance for hepatocellular carcinoma: long way to achieve effectiveness. Dig Dis Sci 2012; 57: 3050-3051 [PMID: 23053890 DOI: 10.1007/s10620-012-2413-z]
6. Cazzagon N, Trevisani F, Maddalo G, Giacomin A, Vanin V, Pozzan C, Poggio PD, Rapaccini G, Nolfo AM, Benvegnù L, Zoli M, Borzio F, Giannini EG, Caturelli E, Chiaramonte M, Foschi FG, Cabibbo G, Felder M, Ciccarese F, Missale G, Baroni GS, Morisco F, Pecorelli A, Farinati F. Rise and fall of HCV-related hepatocellular carcinoma in Italy: a long-term survey from the ITA.LI.CA centres. Liver Int 2013; 33: 1420-1427 [PMID: 23758775 DOI: 10.1111/liv.12208]
7. Marra M, Sordelli IM, Lombardi A, Lamberti M, Tarantino L, Giudice A, Stiuso P, Abbruzzese A, Sperlongano R, Accardo M, Agresti M, Caraglia M, Sperlongano P. Molecular targets and oxidative stress biomarkers in hepatocellular carcinoma: an overview. J Transl Med 2011; 9: 171 [PMID: 21985599 DOI: 10.1186/1479-5876-9-171]
8. Marx J. Cancer research. Inflammation and cancer: the link grows stronger. Science 2004; 306: 966-968 [PMID: 15528423 DOI: 10.1126/science.306.5698.966]
9. Kuchino Y, Mori F, Kasai H, Inoue H, Iwai S, Miura K, Oht-suka E, Nishimura S. Misreading of DNA templates containing 8-hydroxydeoxyguanosine at the modified base and at adjacent residues. Nature 1987; 327: 77-79 [PMID: 3574469 DOI: 10.1038/327077a0]
10. Sawa T, Ohshima H. Nitrative DNA damage in infamma-tion and its possible role in carcinogenesis. Nitric Oxide 2006; 14: 91-100 [PMID: 16099698 DOI: 10.1016/j.niox.2005.06.005]
11. Crowell JA, Steele VE, Sigman CC, Fay JR. Is inducible nitric oxide synthase a target for chemoprevention? Mol Cancer Ther 2003; 2: 815-823 [PMID: 12939472]
12. Hofseth LJ. Nitric oxide as a target of complementary and alternative medicines to prevent and treat infammation and cancer. Cancer Lett 2008; 268: 10-30 [PMID: 18440130 DOI: 10.1016/j.canlet.2008.03.024]
13. Koike K, Tsutsumi T, Fujie H, Shintani Y, Kyoji M. Molecular mechanism of viral hepatocarcinogenesis. Oncology 2002; 62 Suppl 1: 29-37 [PMID: 11868782]
14. Cardin R, Saccoccio G, Masutti F, Bellentani S, Farinati F, Tiribelli C. DNA oxidative damage in leukocytes correlates with the severity of HCV-related liver disease: validation in an open population study. J Hepatol 2001; 34: 587-592 [PMID: 11394660]
15. Shimoda R, Nagashima M, Sakamoto M, Yamaguchi N, Hirohashi S, Yokota J, Kasai H. Increased formation of oxi-dative DNA damage, 8-hydroxydeoxyguanosine, in human livers with chronic hepatitis. Cancer Res 1994; 54: 3171-3172 [PMID: 8205535]
16. Farinati F, Cardin R, Degan P, De Maria N, Floyd RA, Van Thiel DH, Naccarato R. Oxidative DNA damage in circulating leukocytes occurs as an early event in chronic HCV infection. Free Radic Biol Med 1999; 27: 1284-1291 [PMID: 10641722]
17. Farinati F, Cardin R, Bortolami M, Burra P, Russo FP, Rugge M, Guido M, Sergio A, Naccarato R. Hepatitis C virus: from oxygen free radicals to hepatocellular carcinoma. J Viral Hepat 2007; 14: 821-829 [PMID: 18070284 DOI: 10.1111/ j.1365-2893.2007.00878.x]
18. Shinmura K, Yokota J. The OGG1 gene encodes a repair enzyme for oxidatively damaged DNA and is involved in human carcinogenesis. Antioxid Redox Signal 2001; 3: 597-609 [PMID: 11554447 DOI: 10.1089/15230860152542952]
19. Ide H, Kotera M. Human DNA glycosylases involved in the repair of oxidatively damaged DNA. Biol Pharm Bull 2004; 27: 480-485 [PMID: 15056851]
20. Michel S, Wanet A, De Pauw A, Rommelaere G, Arnould T, Renard P. Crosstalk between mitochondrial (dys)function and mitochondrial abundance. J Cell Physiol 2012; 227: 2297-2310 [PMID: 21928343 DOI: 10.1002/jcp.23021]
21. Malik AN, Czajka A. Is mitochondrial DNA content a potential biomarker of mitochondrial dysfunction? Mitochondrion 2013; 13: 481-492 [PMID: 23085537 DOI: 10.1016/ j.mito.2012.10.011]
22. Ralph SJ, Rodríguez-Enríquez S, Neuzil J, Saavedra E, More-no-Sánchez R. The causes of cancer revisited: "mitochondrial malignancy" and ROS-induced oncogenic transformation - why mitochondria are targets for cancer therapy. Mol Aspects Med 2010; 31: 145-170 [PMID: 20206201 DOI: 10.1016/ j.mam.2010.02.008]
23. Severi T, van Malenstein H, Verslype C, van Pelt JF. Tumor initiation and progression in hepatocellular carcinoma: risk factors, classifcation, and therapeutic targets. Acta Pharmacol Sin 2010; 31: 1409-1420 [PMID: 20953207 DOI: 10.1038/ aps.2010.142]
24. Angelico F, Francioso S, Del Ben M, Feole K, Carbone M, Pignatelli P, Violi F, Angelico M. Clinical trial: low plasma cholesterol and oxidative stress predict rapid virological response to standard therapy with peginterferon and ribavirin in HCV patients. Aliment Pharmacol Ther 2009; 30: 444-451 [PMID: 19493257 DOI: 10.1111/j.1365-2036.2009.04055.x]
25. Morisco F, Verde V, Fogliano V, Ritieni A, Marmo R, De Luise G, Tuccillo C, Caporaso N. Oxidative status in chronic hepatitis C: the influence of antiviral therapy and prognostic value of serum hydroperoxide assay. Free Radic Res 2004; 38: 573-580 [PMID: 15346648]
26. Marotta F, Yoshida C, Barreto R, Naito Y, Packer L. Oxi-dative-inflammatory damage in cirrhosis: effect of vitamin E and a fermented papaya preparation. J Gastroenterol Hepatol 2007; 22: 697-703 [PMID: 17444858 DOI: 10.1111/ j.1440-1746.2007.04937.x]
27. Vitaglione P, Fogliano V, Stingo S, Scalfi L, Caporaso N, Morisco F. Development of a tomato-based food for special medical purposes as therapy adjuvant for patients with HCV infection. Eur J Clin Nutr 2007; 61: 906-915 [PMID: 17180159 DOI: 10.1038/sj.ejcn.1602571]
28. Gomez EV, Perez YM, Sanchez HV, Forment GR, Soler EA, Bertot LC, Garcia AY, del Rosario Abreu Vazquez M, Fabian LG. Antioxidant and immunomodulatory effects of Viusid in patients with chronic hepatitis C. World J Gastroenterol 2010; 16: 2638-2647 [PMID: 20518086]
29. Melhem A, Stern M, Shibolet O, Israeli E, Ackerman Z, Pappo O, Hemed N, Rowe M, Ohana H, Zabrecky G, Cohen R, Ilan Y. Treatment of chronic hepatitis C virus infection via antioxidants: results of a phase I clinical trial. J Clin Gastroen-terol 2005; 39: 737-742 [PMID: 16082287]
30. Kryston TB, Georgiev AB, Pissis P, Georgakilas AG. Role of oxidative stress and DNA damage in human carcinogenesis. Mutat Res 2011; 711: 193-201 [PMID: 21216256 DOI: 10.1016/ j.mrfmmm.2010.12.016]
31. Moriya K, Nakagawa K, Santa T, Shintani Y, Fujie H, Miyo-shi H, Tsutsumi T, Miyazawa T, Ishibashi K, Horie T, Imai K, Todoroki T, Kimura S, Koike K. Oxidative stress in the absence of inflammation in a mouse model for hepatitis C virus-associated hepatocarcinogenesis. Cancer Res 2001; 61: 4365-4370 [PMID: 11389061]
32. Mišík M, Hoelzl C, Wagner KH, Cavin C, Moser B, Kundi M, Simic T, Elbling L, Kager N, Ferk F, Ehrlich V, Nersesyan A, Dušinská M, Schilter B, Knasmüller S. Impact of paper fltered coffee on oxidative DNA-damage: results of a clinical trial. Mutat Res 2010; 692: 42-48 [PMID: 20709087 DOI: 10.1016/j.mrfmmm.2010.08.003]
33. Ikeda K, Arase Y, Kobayashi M, Saitoh S, Someya T, Hosaka T, Sezaki H, Akuta N, Suzuki Y, Suzuki F, Kumada H. A long-term glycyrrhizin injection therapy reduces hepatocel-lular carcinogenesis rate in patients with interferon-resistant active chronic hepatitis C: a cohort study of 1249 patients. Dig Dis Sci 2006; 51: 603-609 [PMID: 16614974 DOI: 10.1007/ s10620-006-3177-0]
34. Yu H, Pardoll D, Jove R. STATs in cancer infammation and immunity: a leading role for STAT3. Nat Rev Cancer 2009; 9: 798-809 [PMID: 19851315 DOI: 10.1038/nrc2734]
35. Ramadori G, Armbrust T. Cytokines in the liver. Eur J Gas-troenterol Hepatol 2001; 13: 777-784 [PMID: 11474306]
36. Nakazaki H. Preoperative and postoperative cytokines in patients with cancer. Cancer 1992; 70: 709-713 [PMID: 1320454]
37. Bortolami M, Venturi C, Giacomelli L, Scalerta R, Bacchetti S, Marino F, Floreani A, Lise M, Naccarato R, Farinati F. Cyto-kine, infiltrating macrophage and T cell-mediated response to development of primary and secondary human liver cancer. Dig Liver Dis 2002; 34: 794-801 [PMID: 12546515]
38. Leonardi GC, Candido S, Cervello M, Nicolosi D, Raiti F, Travali S, Spandidos DA, Libra M. The tumor microenviron-ment in hepatocellular carcinoma (review). Int J Oncol 2012; 40: 1733-1747 [PMID: 22447316 DOI: 10.3892/ijo.2012.1408]
39. Wheelhouse NM, Chan YS, Gillies SE, Caldwell H, Ross JA, Harrison DJ, Prost S. TNF-alpha induced DNA damage in primary murine hepatocytes. Int J Mol Med 2003; 12: 889-894 [PMID: 14612962]
40. Liu TZ, Lee KT, Chern CL, Cheng JT, Stern A, Tsai LY. Free radical-triggered hepatic injury of experimental obstructive jaundice of rats involves overproduction of proinfammatory cytokines and enhanced activation of nuclear factor kappaB. Ann Clin Lab Sci 2001; 31: 383-390 [PMID: 11688850]
41. Vermeulen K, Berneman ZN, Van Bockstaele DR. Cell cycle and apoptosis. Cell Prolif 2003; 36: 165-175 [PMID: 12814432]
42. Hironaka K, Factor VM, Calvisi DF, Conner EA, Thorgeirs-son SS. Dysregulation of DNA repair pathways in a transforming growth factor alpha/c-myc transgenic mouse model of accelerated hepatocarcinogenesis. Lab Invest 2003; 83: 643-654 [PMID: 12746474]
43. Lapiński TW. The levels of IL-1beta, IL-4 and IL-6 in the serum and the liver tissue of chronic HCV-infected patients. Arch Immunol Ther Exp (Warsz) 2001; 49: 311-316 [PMID: 11726034]
44. Bahr MJ, El Menuawy M, Boeker KH, Musholt PB, Manns MP, Lichtinghagen R. Cytokine gene polymorphisms and the susceptibility to liver cirrhosis in patients with chronic hepatitis C. Liver Int 2003; 23: 420-425 [PMID: 14986816]
45. Tanaka Y, Furuta T, Suzuki S, Orito E, Yeo AE, Hirashima N, Sugauchi F, Ueda R, Mizokami M. Impact of interleukin-1beta genetic polymorphisms on the development of hepatitis C virus-related hepatocellular carcinoma in Japan. J Infect Dis 2003; 187: 1822-1825 [PMID: 12751042 DOI: 10.1086/375248]
46. Farinati F, Cardin R, Bortolami M, Guido M, Rugge M. Oxi-dative damage, pro-infammatory cytokines, TGF-alpha and c-myc in chronic HCV-related hepatitis and cirrhosis. World J Gastroenterol 2006; 12: 2065-2069 [PMID: 16610058]
47. Gramantieri L, Casali A, Trerè D, Gaiani S, Piscaglia F, Chieco P, Cola B, Bolondi L. Imbalance of IL-1 beta and IL-1 receptor antagonist mRNA in liver tissue from hepatitis C virus (HCV)-related chronic hepatitis. Clin Exp Immunol 1999; 115: 515-520 [PMID: 10193427]
48. Giannoni E, Parri M, Chiarugi P. EMT and oxidative stress: a bidirectional interplay affecting tumor malignancy. Anti-oxid Redox Signal 2012; 16: 1248-1263 [PMID: 21929373 DOI: 10.1089/ars.2011.4280]
49. Rhyu DY, Yang Y, Ha H, Lee GT, Song JS, Uh ST, Lee HB. Role of reactive oxygen species in TGF-beta1-induced mitogen-activated protein kinase activation and epithelial-mesenchymal transition in renal tubular epithelial cells. J Am Soc Nephrol 2005; 16: 667-675 [PMID: 15677311]
50. Artandi SE, DePinho RA. Telomeres and telomerase in cancer. Carcinogenesis 2010; 31: 9-18 [PMID: 19887512 DOI: 10.1093/carcin/bgp268]
51. Monaghan P. Telomeres and life histories: the long and the short of it. Ann N Y Acad Sci 2010; 1206: 130-142 [PMID: 20860686 DOI: 10.1111/j.1749-6632.2010.05705.x]
52. Houben JM, Moonen HJ, van Schooten FJ, Hageman GJ. Telomere length assessment: biomarker of chronic oxidative stress? Free Radic Biol Med 2008; 44: 235-246 [PMID: 18021748 DOI: 10.1016/j.freeradbiomed.2007.10.001]
53. Lambert MP, Paliwal A, Vaissière T, Chemin I, Zoulim F, Tommasino M, Hainaut P, Sylla B, Scoazec JY, Tost J, Herceg Z. Aberrant DNA methylation distinguishes hepatocellular carcinoma associated with HBV and HCV infection and alcohol intake. J Hepatol 2011; 54: 705-715 [PMID: 21146512 DOI: 10.1016/j.jhep.2010.07.027]
54. Ozen C, Yildiz G, Dagcan AT, Cevik D, Ors A, Keles U, To-pel H, Ozturk M. Genetics and epigenetics of liver cancer. N Biotechnol 2013; 30: 381-384 [PMID: 23392071 DOI: 10.1016/ j.nbt.2013.01.007]
55. Chiodi I, Mondello C. Telomere-independent functions of telomerase in nuclei, cytoplasm, and mitochondria. Front Oncol 2012; 2: 133 [PMID: 23061047 DOI: 10.3389/ fonc.2012.00133]
56. Indran IR, Hande MP, Pervaiz S. hTERT overexpression alleviates intracellular ROS production, improves mitochon-drial function, and inhibits ROS-mediated apoptosis in cancer cells. Cancer Res 2011; 71: 266-276 [PMID: 21071633 DOI: 10.1158/0008-5472.CAN-10-1588]
57. Saretzki G. Telomerase, mitochondria and oxidative stress. Exp Gerontol 2009; 44: 485-492 [PMID: 19457450 DOI: 10.1016/j.exger.2009.05.004]
58. Sharma NK, Reyes A, Green P, Caron MJ, Bonini MG, Gordon DM, Holt IJ, Santos JH. Human telomerase acts as a hTR-independent reverse transcriptase in mitochondria. Nucleic Acids Res 2012; 40: 712-725 [PMID: 21937513 DOI: 10.1093/nar/gkr758]
59. Haendeler J, Dröse S, Büchner N, Jakob S, Altschmied J, Goy C, Spyridopoulos I, Zeiher AM, Brandt U, Dimmeler S. Mitochondrial telomerase reverse transcriptase binds to and protects mitochondrial DNA and function from damage. Ar-terioscler Thromb Vasc Biol 2009; 29: 929-935 [PMID: 19265030 DOI: 10.1161/ATVBAHA.109.185546]
60. Gailhouste L, Gomez-Santos L, Ochiya T. Potential applications of miRNAs as diagnostic and prognostic markers in liver cancer. Front Biosci (Landmark Ed) 2013; 18: 199-223 [PMID: 23276918]
61. Ebert MS, Sharp PA. Roles for microRNAs in conferring robustness to biological processes. Cell 2012; 149: 515-524 [PMID: 22541426 DOI: 10.1016/j.cell.2012.04.005]
62. Kozomara A, Griffiths-Jones S. miRBase: integrating mi-croRNA annotation and deep-sequencing data. Nucleic Acids Res 2011; 39: D152-D157 [PMID: 21037258 DOI: 10.1093/nar/ gkq1027]
63. Dong X, Liu H, Chen F, Li D, Zhao Y. MiR-214 Promotes the Alcohol-Induced Oxidative Stress via Down-Regulation of Glutathione Reductase and Cytochrome P450 Oxidoreduc-tase in Liver Cells. Alcohol Clin Exp Res 2014; 38: 68-77 [PMID: 23905773 DOI: 10.1111/acer.12209]
64. Dai BH, Geng L, Wang Y, Sui CJ, Xie F, Shen RX, Shen WF, Yang JM. microRNA-199a-5p protects hepatocytes from bile acid-induced sustained endoplasmic reticulum stress. Cell Death Dis 2013; 4: e604 [PMID: 23598416 DOI: 10.1038/cd-dis.2013.134]
65. Tsai WC, Hsu PW, Lai TC, Chau GY, Lin CW, Chen CM, Lin CD, Liao YL, Wang JL, Chau YP, Hsu MT, Hsiao M, Huang HD, Tsou AP. MicroRNA-122, a tumor suppressor microR-NA that regulates intrahepatic metastasis of hepatocellular carcinoma. Hepatology 2009; 49: 1571-1582 [PMID: 19296470 DOI: 10.1002/hep.22806]
66. Cheung O, Puri P, Eicken C, Contos MJ, Mirshahi F, Maher JW, Kellum JM, Min H, Luketic VA, Sanyal AJ. Nonalcoholic steatohepatitis is associated with altered hepatic MicroRNA expression. Hepatology 2008; 48: 1810-1820 [PMID: 19030170 DOI: 10.1002/hep.22569]
67. Hou W, Tian Q, Steuerwald NM, Schrum LW, Bonkovsky HL. The let-7 microRNA enhances heme oxygenase-1 by suppressing Bach1 and attenuates oxidant injury in human hepatocytes. Biochim Biophys Acta 2012; 1819: 1113-1122 [PMID: 22698995 DOI: 10.1016/j.bbagrm.2012.06.001]
68. Boesch-Saadatmandi C, Wagner AE, Wolffram S, Rimbach G. Effect of quercetin on inflammatory gene expression in mice liver in vivo - role of redox factor 1, miRNA-122 and miRNA-125b. Pharmacol Res 2012; 65: 523-530 [PMID: 22402395 DOI: 10.1016/j.phrs.2012.02.007]
69. Lee CG, Kim YW, Kim EH, Meng Z, Huang W, Hwang SJ, Kim SG. Farnesoid X receptor protects hepatocytes from injury by repressing miR-199a-3p, which increases levels of LKB1. Gastroenterology 2012; 142: 1206-1217.e7 [PMID: 22265968 DOI: 10.1053/j.gastro.2012.01.007]
70. Li N, Muthusamy S, Liang R, Sarojini H, Wang E. Increased expression of miR-34a and miR-93 in rat liver during aging, and their impact on the expression of Mgst1 and Sirt1. Mech Ageing Dev 2011; 132: 75-85 [PMID: 21216258 DOI: 10.1016/ j.mad.2010.12.004]
71. Hou W, Tian Q, Zheng J, Bonkovsky HL. MicroRNA-196 represses Bach1 protein and hepatitis C virus gene expression in human hepatoma cells expressing hepatitis C viral proteins. Hepatology 2010; 51: 1494-1504 [PMID: 20127796 DOI: 10.1002/hep.23401]
72. Romilda C, Marika P, Alessandro S, Enrico L, Marina B, Andromachi K, Umberto C, Giacomo Z, Claudia M, Massimo R, Fabio F. Oxidative DNA damage correlates with cell immortalization and mir-92 expression in hepatocellular carcinoma. BMC Cancer 2012; 12: 177 [PMID: 22587342 DOI: 10.1186/1471-2407-12-177]
73. Choi JJ, Reich CF, Pisetsky DS. Release of DNA from dead and dying lymphocyte and monocyte cell lines in vitro. Scand J Immunol 2004; 60: 159-166 [PMID: 15238085 DOI: 10.1111/j.0300-9475.2004.01470.x]
74. Alix-Panabières C, Schwarzenbach H, Pantel K. Circulating tumor cells and circulating tumor DNA. Annu Rev Med 2012; 63: 199-215 [PMID: 22053740 DOI: 10.1146/annurev-med-062310-094219]